Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel-Reference-Cited by-同舟云学术

Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel

Published:2009-06 Issue:3 Volume:64 Page:326-333
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Azuma Koichi,Sasada Tetsuro,Kawahara Akihiko,Takamori Sinzo,Hattori Satoshi,Ikeda Jiro,Itoh Kyogo,Yamada Akira,Kage Masayoshi,Kuwano Michihiko,Aizawa Hisamichi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Randomized phase III study of cisplatin plus irrinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan;Ohe;Ann Oncol,2007

2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

3. Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?;Seve;Lancet Oncol,2008

4. Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer;Gan;Cancer Res,2007

5. Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel;Seve;Mol Cancer Ther,2005

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotyping, in silico screening and molecular dynamics simulation of SNPs of MGMT and ERCC1 gene in lung cancer patients treated with platinum-based doublet chemotherapy;Journal of Biomolecular Structure and Dynamics;2023-09-28

2. Sulfonamide derivatives mediate breast and lung cancer cell line killing through tubulin inhibition;Journal of Molecular Structure;2022-11

3. Personalized Prescription of Chemotherapy Based on Assessment of mRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer;Journal of Personalized Medicine;2022-10-04

4. International consensus on severe lung cancer—the first edition;Translational Lung Cancer Research;2021-06

5. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study;Cancer Chemotherapy and Pharmacology;2019-01-14